Abstract-Heterologous expression of the moenomycin biosynthesis gene cluster (moe) would be one of the ways to reach this goal. Here, we report the generation of a number of novel heterologous streptomycete hosts producing nosokomycin A 2 (one of the members of Mm family) and determine their potential for the antibi otic production. The rpoB point mutation in the model strain of Streptomyces coelicolor (strain M1152) sig nificantly improved nosokomycin A 2 production compared to parental strains (M145 and M512), while dou ble rpoBrpsL mutation in the same species (strain M1154) decreased it. Our results point to the previously unanticipated epistatic interactions between mutations that individually are known to be highly beneficial for antibiotic production. We also showed here for the first time that facultative chemolitotrophic strepto mycete S. thermospinosisporus and chloramphenicol producer S. venezuelae can be used as the hosts for moe genes.
INTRODUCTION
Shortage in development of novel antibiotics over the last two decades has created numerous challenges for healthcare worldwide and renewed the interest in many underdeveloped classes of natural products. Moenomycins (Mm; Fig. 1 ), phosphoglycolipid natu ral products of streptomycete origin, are one such class. Mm directly inhibit peptidoglycan glycosyl transferases (PGTs), enzymes involved in penultimate step of bacterial cell wall biosynthesis [1] . There are no currently drugs on the market that would act through PGT inhibition. For more than four decades of use in animal nutrition, Mm have not led to a significant increase in moenomycin resistance among clinically relevant bacteria [2] . Mm are extremely active against cocci, with an average minimal inhibitory concentra tion (MIC) 10 to 1000 fold lower (depending on the strain) than that for vancomycin, another currently used antibiotic. These remarkable traits notwithstand ing, the development of Mm into a drug is compli cated by its very low oral bioavailability and long half life in the bloodstream-two properties that are thought to be determined by the long isoprenoid chain 1 The article was translated by the authors.
in Mm structure ( Fig. 1) [3] . It's therefore important to explore all possible ways to manipulate Mm struc ture in order to obtain improved analogs. Currently submerged fermentation of Mm producers is the only economically justified way to produce this class of compounds, although available strains accumulate small amounts of Mm.
Recently the cluster for Mm production (moe) has recently been cloned from Streptomyces ghanaensis (ATCC14672), and its biosynthesis has been deci phered. All moe genes, except for three controlling the formation of the A ring ( Fig. 1) and its attachment to the glycoside portion of Mm, are located within moe cluster 1 [3] . Yet, it is not clear to date how the regula tion of Mm is accomplished. This, to a large extent slows down all genetic engineering of moenomycin variants.
Production of several different moenomycins has also been achieved in heterologous strains, such as S. lividans TK24, S. coelicolor M145 and S. albus J1074 [4] . Although the amounts of Mm produced by heter ologous hosts do not exceed that of ATCC14672, the ease of genetic manipulations, faster growth, and sim pler schemes of compound purification are the chief advantages of heterologous systems. We therefore decided to investigate a wider set of Streptomyces strains as a platform for Mm production, with the aim to obtain new insights into the genetic mechanisms of regulation, as well as to identify improved heterolo gous hosts. In this work, we focused on the production of nosokomycin A 2 (NoA 2 ; Fig. 1 ). This is one of the structurally simpler members of Mm family, and it is suitable for further chemical or enzymatic modifica tion [5] . We have chosen six streptomycete strains (described in Results section in more details) for our heterologous expression experiments. Among other results, we revealed an unexpected genetic interaction between rроВ and rpsL mutations that diminished moenomycin titers. We also show here for the first time that chemolitotrophic streptomycete can be manipu lated genetically and used for the heterologous pro duction of antibiotics.
MATERIALS AND METHODS

Strains and Cosmid DNAs
Escherichia coli ET12567 (pUZ8002) was used for the conjugative DNA transfer from E. coli to Strepto myces. Bacillus cereus ATCC 19637 was used as a test culture in Mm activity bioassays. S. ghanaensis dH5 is a moeH5 deletion derivative of ATCC14672; it accu mulates exclusively nosokomycin A (NoA; Fig. 1 [7] , S. venezuelae ATCC10712 (wild type) [8, 9] , S. thermospinosisporus NRRL B24318 (=AT10 T = DSM 41779 T ) (wild type) [10] .
Cosmid moeno 38 6 ( Fig. 2) was used for heterol ogous expression experiments. Its construction is fully described in [11] . It includes the attP int fragment of the actinophage ϕC31 genome, enabling site specific integration of the cosmid into attB ϕC31 [12] . The cosmid contains the entire major moe cluster, except for moeR5moeS5 genes, and moeH5 was substituted with kanamycin resistance gene neo. Because of the absence of the moeH5, moeR5moeS5 genes, moeno38 6 directs the biosynthesis of NoA 2 [3, 11] . All strains and plasmids are maintained in the Collection of cultures of microorganisms producers of antibiotics of Ivan Franko National University of Lviv. LOPATNIUK et al.
Culture Conditions B. cereus and E. coli strains were cultured as described [13] . To produce spores, the streptomycetes were grown on oatmeal agar [14] or MYM [15] from 2 to 8 days (depending on the strain) at 28°C, (S. gha naensis and S. thermospinosisporus-at 37°C). To examine NoA 2 biosynthesis, moeno38 6 + Streptomy ces strains were grown in liquid R5A [4] or TSB (BD, USA) and on solid agar soybean medium (g/L: soy flour, 20; NaCl, 5; agar, 16). Conjugal matings strep tomycetes were grown on oatmeal or soymeal media. Heterologous host strains carrying moeno38 6 were grown in the presence of kanamycin (50 μg mL -1 ) and hygromycin (100 μg mL -1 ).
Verification of the Strains Containing Cosmid Moeno38 6
and Analysis of Nosokomycin A 2 Production Transconjugants were checked for the stability of kanamycin and hygromycin resistance after three passages under nonselective conditions (oatmeal agar without antibiotics). Then we used PCR to prove the presence of moeno 38 6 in the chromosome of the strains. For this purpose, we used primers moeO5up and moeO5rev [11] designed to amplify the key gene for Mm biosynthesis, moeO5. Using total DNA as a template, in all cases we observed the amplicon of expected size (1.3 kb), confirming the presence of moeno38 6 in transconjugants.
A set of bioassays was used to determine the antibi otic activity of the actinomycete strains: the produc tivity index (IP), the ratio of the diameter of the growth inhibition zone around the clone to the diam eter of the latter [16] ; the agar plug method [17] , anti biotic disc diffusion assay [4] . All LC MS data were acquired on a Bruker Esquire 3000 ESI MS machine as described in [4] . Following compounds (shown on Fig. 1 
RESULTS
Choice of Novel Heterologous Hosts
for NoA 2 Production We previously showed that S. albus J1074 and S. coelicolor M145 can be used for the heterologous production of nosokomycin В 2 ( Fig. 1) [4] . The first of the mentioned strains exhibited a relatively high Mm production level approaching that of native strain, ATCC14672, and we also decided to use this strain for NoA 2 production. S. coelicolor M145 was character ized by very low NoB 2 production. Two strains, M1152 and M1154, have been recently constructed on the basis of M145 with antibiotic overproducing proper ties [9] . In both strains endogenous gene clusters for biosynthesis of actinorhodin, undecylprodigiosin, CPK, and CDA have been deleted. Furthermore, in strain M1152 there point mutation S433L has been introduced into the gene rpoB for a RNA polymerase subunit. The strain M1154 carries rpoB mutation along with mutation in ribosomal protein S12 (rpsL; [K88E]). These pleiotropic mutations are known to increase antibiotic production by various actinobacte ria [18] [19] [20] [21] , and we decided to test their influence on Mm production. Next, we have chosen S. venezuelae (ATCC 10712) because of its fast dispersed growth and simplicity of genetic manipulations (particularly ame nability to electroporation and high frequency of trasnconjugants in matings with E. coli) [8, 9] . Finally, we expressed moe genes in thermophilic carboxy dotrophic S. thermospinosisporus (NRRL B24318) [10] as a first step in the evaluation of a possibility use of chemolitotrophic bacteria for Mm production.
Generation and Verification of Heterologous Hosts
for NoA 2 Biosynthesis The cosmid moeno38 6 ( Fig. 2) We checked the Mm production by the heterolo gous hosts using LC MS. All the transconjugants pro duced the expected compound, NoA 2 , as exemplified on Fig. 3 by extract from the moeno38 6 + M1152 and J1074 strains. Interestingly, although moeno38 6 + J1074 strain produced NoA 2 , it was not a major Mm in the extract. Instead, tetrasaccharide intermediate to NoA 2 (lacking terminal galacturonic residue, see Fig. 1 ) dominated the extract, accounting roughly for 90% of Mm content (Fig. 3) . The parental strains did not pro duce Mm in the absence of moeno38 6 (data not shown).
Analysis of Mm Production
Although LC MS allows precise qualitative detec tion of Mm in the extracts, it is very time consuming and nontrivial method for quantitative analysis. More over, when one plans to test many strains under numerous conditions, it becomes economically pro hibitive. To quantify Mm production, we routinely used various bioassays tailored to the needs of the experiment [4, 22] . However no side by side compar ison of these methods has ever been carried out. We therefore set out to address this question, which will help to develop a bioassay based method of analysis of many clones, giving a reliable prediction of the pro ductivity under submerged fermentation conditions. There were tested two approaches based on growth of Mm producer on solid media and one based on analy sis of extracts from the biomass from liquid media. Results of these measurements are summarized on Fig. 4 . LC MS of the extracts from the biomass grown in liq uid media was then employed for verification; these data turned out to coincide with IP bioassay data (Fig. 4a) , and we cite them below. S. albus J1074 produced the highest Mm titers when growing on either solid or in liquid media (a 1.5 fold increase in IP as compared to S. ghanaensis dH5). This is in contrast to the S. vene zuelae strain, which produced minute quantities of Mm in liquid R5A, although it seemed to accumulate them more abundantly on soybean agar. Perhaps, it is explained by the increased NoA 2 production on that medium, as well as the co production of chloram phenicol (Figs. 4a and 4b ). We observed a rather high level of moenomycin production by S. thermospino sisporus, which was within the range of productivity of the M1152 moeno38 6 + strain (Fig. 4a) .
Intriguing results could be inferred from the com parison of NoA 2 production levels of S. coelicolor M145, M1152 and M1154 strains. In comparison to M145 or M512 [4] , the rpoB mutation (strain M1152) alone increased NoA 2 production 1.6 fold. Neverthe less, a combination of rpoB and rpsL mutations (strain M1154) decreased NoA 2 production 2 and 3 fold in comparison to M145 and M1152, respectively. The S. coelicolor strains did not differ in growth rate or bio mass accumulation.
DISCUSSION
Here we report the generation and study of several novel heterologous strains for Mm. The choice of novel heterologous strains was based on their benefi cial genetic or microbiological traits, as detailed in the first section of Results. As a model, we used the cosmid Mm production level of the parent strain is considered 100%, which is approx imately 1 mg/L of liquid medium TSB. Column labels: S.gh., S. ghanaensis dH5; S.alb m, S. albus moeno38 6; S.ven m, S. ven ezuelae moeno38 6; S.th m, S. thermospinisporus moeno38 6; M145 m, M145 moeno38 6; M1152 m, M1152 moeno38 6 + -rpoB mutant; M1154 m, M1154 moeno38 6 + rpoBrpsL mutant. * The bioactivity value represents the total antibiotic activity of Mm and chloramphenicol. moeno38 6 that directs the production of NoA 2 . There is significant industrial interest in this molecule as a scaffold for further chemical or bioenzymatic derivatization, although its availability is very limited. Production of NoA 2 was previously shown by us in S. lividans TK24 [6] , but its purification was compli cated by the presence of endogenous metabolites of S. lividans, such as actinorhodin. This work therefore establishes for the first time a route to reliable fermen tation based access to NoA 2 as a final and major com pound. On combining the results of different methods of analysis of NoA 2 production by the heterologous hosts, we gained useful insight into the biosynthesis of Mm and the methodology of their quantification.
We first discuss the methodological aspects of our work, which provide the necessary foundation for the analysis of the obtained data. Several different bioas says were tested as a way to obtain semiquantitative data on the productivity of the generated heterologous hosts. Their further verification via LC MC provided evidence that measurement of the IP of colonies grown on solid media most precisely reflects the pro ductivity of strains under submerged fermentation conditions. Disc diffusion method was not so reliable, probably because it was difficult to guess the amount of compound applied to the disc. If it exceeded certain value, the diffusion of Mm could be compromised by micelle formation, a known problem for all lipid con taining metabolites [3] . The agar block method had several shortcomings too, such as low diffusion from the blocks, unequal diffusion from the blocks of even slightly different heights, or changes in the size and density of the blocks due to agarolytic activity of acti nomycetes (the latter was observed for S. coelicolor M1152 and M1154 strains). This led us to consider IP measurement a method of choice for future experi ments.
Of the entire set of strains being tested, S. albus J1074 at first appeared to be the most promising host for NoA 2 production. However, as LC MS analysis showed, the total antibiotic activity of J1074 moeno38 6 + resulted from the accumulation of two different Mm-NoA 2 and its tetrasaccharide interme diate. The latter is dominant in the mixture (Fig. 4) . Either the production of galacturonic acid (a building block of the terminal sugar residue in Mm) is a bottle neck step in J1074 metabolism, or the expression of the moe gene for glycosyltransferase MoeGT2 (attaches the last sugar in Mm biosynthetic pathway [11] ) is for some reason decreased in J1074.
Selection for certain streptomycin and/or rifampicin resistant mutants of antibiotic produc ers-is well known and is a widespread method to improve productivity [18, 23, 24] . The use of hetero logous hosts genetically engineered to bear such muta tions is one way around the tedious process of the selection and isolation of such mutants, and we took this approach in our work. Our results showed the util ity of rpoB mutation for the improvement of NoA 2 production by S. coelicolor M1152 moeno38 6 + . The M1152 moeno38 6 + strain is currently being consid ered by us as the most promising platform for NoA 2 production. The combination of rpoB and rpsL (A262G) mutations unexpectedly decreased NoA 2 production (by 50%), below the level of parental strain M145. We showed previously that the same rpsL muta tion in S. lividans had no effect on Mm production [4] . This work demonstrates for the first time that rpsL mutations could be not only beneficial or neutral with respect to secondary metabolism, but deleterious as well, particularly in combination with rpoB mutation. While each mutation alone increases antibiotic pro duction (or is at least neutral), their combination pro duces a clear epistatic effect. This might be caused by the overall negative influence of double rpoBrpsL mutation on growth of M1154 strain, as already has been noted by the researchers who developed it [18] . Probably, unlike the production of polyketides or non ribosomal peptides, the biosynthesis of glycoside rich molecules, such as moenomycins, is very strictly co regulated with certain essential primary metabolic pathways, and any perturbation in the latter lead to decreases in antibiotic production. We note that in course of analysis of big collections of streptomycin and rifampicin resistant mutants only a few had signif icantly produced more antibiotic, whereas the major ity accumulated the latter at or below the wild type level [23] [24] [25] . Our results provide a cautionary tale about the challenges in generating optimal expression host through the accumulation of pleiotropic muta tions [26, 27] .
S. venezuelae has recently entered the arena of Streptomyces genetics as a novel model for fundamen tal studies and heterologous expression experiments [8, 9] . Indeed, this strain showed fast and fine growth under Mm production conditions, but it also co pro duced chloramphenicol and other colored com pound(s), confounding the results of bioassays. There fore, the real NoA 2 titer of S. venezuelae is low, sug gesting an unfriendly genetic background for Mm production, and/or nonoptimal nutritional condi tions. This latter explains the trace production of NoA 2 in R5A. In contrast, S. thermospinosisporus did not excrete any colored metabolite or compound active against Mm test culture. It produces NoA 2 as well as M1152 does, indicating its good prospects as a platform for Mm production. There are no reports in the literature on the transfer of foreign DNA into S. thermospinosisporus, or any other genetic manipula tions with this chemolitotrophic strain. So our, data are first of its kind. NoA 2 was produced heterotrophi cally in our study, and we currently are testing the pos sibility of its biosynthesis under conditions of carbox ydotrophy and higher temperatures (>37°C). Besides practical goal of making valuable molecules from cheap materials such as CO and CO 2 , this work would help us understand the most fundamental links between primary and secondary metabolism.
